Kaplan-Meier analysis of time to recurrent congestive heart failure or death in patients prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory.

Slides:



Advertisements
Similar presentations
Description of Each Study in the Cross Trial Safety Analysis Solomon SD, et al. Circulation 2008 [Epub Mar 31]
Advertisements

Coronary heart disease (CHD) event rates in secondary prevention and acute coronary syndrome trials A. Kumar, C.P. Cannon. Arch Med Sci 2007;3:S115-S125.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose? Systolic.
Flow Diagram of the Main HOPE Trial and the HOPE-TOO Trial Extension The HOPE and HOPE-TOO Trial Investigators JAMA. 2005;293:
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Cardiovascular Risk and NSAIDs Arthritis Advisory Committee Meeting November 29, 2006 Sharon Hertz, M.D. Deputy Director Division of Analgesia, Anesthesia,
Cardiovascular Risk and NSAIDs Arthritis Advisory Committee Meeting April 12, 2007 Sharon Hertz, M.D. Deputy Director Division of Analgesia, Anesthesia,
Dose and Time-Dependent Effects of Cyclooxygenase-2 Inhibition on Fracture-Healing by Ann Marie Simon, and J. Patrick O'Connor J Bone Joint Surg Am Volume.
Charlotte Kragelund et al N Engl J Med 2005;352: Baseline Clinical Characteristics According to Quartiles of NT-pro-BNP.
Enrollment and Outcomes Duckworth W, et al. N Engl J Med 2009;360:
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Omega-3 Polyunsaturated Fatty Acids and Cardiovascular.
Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence, Temporal Trends, and Prognostic Impact.
Date of download: 6/3/2016 From: Mortality Rates in Elderly Patients Who Take Different Angiotensin-Converting Enzyme Inhibitors after Acute Myocardial.
Date of download: 6/24/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Prognosis of Acute Kidney Injury After.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Overview of the 2011 Food and Drug Administration.
Volume 45, Issue 5, Pages (May 2004)
Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,
Flow of Individuals Through the Vitamin E and Vitamin C Components of the Physicians’ Health Study II Howard D. Sesso et al. JAMA 2008;300:
Copyright © 2000 American Medical Association. All rights reserved.
Table 1. Baseline Characteristics of the 36,636 Study Subjects
Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: Focus on trabectedin  Andrés Poveda, Isabelle Ray-Coquard, Ignacio Romero,
UK Renal Registry 10th Annual Report 2007
Baseline Demographic and Clinic Variables According to Office vs 24-Hour or Home BP Giuseppe Mancia, et al. Hypertension 2006;47;
Copyright © 2006 American Medical Association. All rights reserved.
UK Renal Registry 18th Annual Report
Copyright © 2009 American Medical Association. All rights reserved.
Fig. 1 Kaplan–Meier curves of post-progression survival (PPS) in the docetaxel and best supportive care (BSC) groups. Median PPS was 5.4 months in the.
Volume 120, Issue 3, Pages (February 2001)
NSAIDs: Risk of acute MI compared with remote use
Drug used within 3 months of index date Adjusted odds ratio* p
Baseline characteristics of patients
Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,
Fellström BC, et al. N Engl J Med 2009;360:1455-7
Number of patients who received at least one prescription for a COX-2 inhibitor or NSAID after hospital discharge Drug Patients % of study cohort Rofecoxib.
Volume 80, Issue 9, Pages (November 2011)
Kaplan–Meier estimates of the incidence of first heart failure hospitalization during follow-up according to the statin category among patients with type.
Volume 81, Issue 2, Pages (January 2012)
Daan Kromhout, et al. NEJM epub August 29, 2010
Characteristics of elderly patients prescribed statins after acute myocardial infarction (AMI) in Quebec, Ontario and British Columbia - Part I Zheng.
Baseline Characteristics by Baseline N-BNP Level
Trial profile GISSI-HF investigators. Lancet 2008; Aug 29 [Epub ahead of print]
Trial profile GISSI-HF investigators. Lancet 2008; Aug 29 [Epub ahead of print]
Characteristics of the Patients at Baseline*
Volume 83, Issue 4, Pages (April 2013)
Baseline Characteristics According to Sex
International Journal of Cardiology
Characteristics of Study Subjects and Events, According to the Quintile of Exposure to Fine Particulate Matter (PM2.5)* - Part I Kristin A. Miller et al.
Baseline Characteristics of the Study Participants
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Age-Standardized Rates of Death from Any Cause According to the Estimated GFR among 1,120,295 Ambulatory Adults Alan S.Go et al. N Engl J Med 2004; 351:
Entry, Randomization, and Follow-up of Patients in the Hypertension in the Very Elderly Trial Of the 461 patients who did not meet the protocol criteria,
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Volume 73, Issue 8, Pages (April 2008)
The ACCORD Study Group. NEJM 2010; Epub March 14
Volume 74, Issue 8, Pages (October 2008)
Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients  Finnian R. Mc Causland, Sushrut S.
The ACCORD Study Group. NEJM 2010; Epub March 14
Flow chart of search strategy
Volume 68, Issue 1, Pages (July 2005)
T2DM patients with HF may benefit from SGLT2 inhibitor therapy
Volume 75, Issue 1, Pages (January 2009)
Davide Capodanno et al. JCIN 2009;2:
Prosthesis–patient mismatch after aortic valve replacement predominantly affects patients with preexisting left ventricular dysfunction: Effect on survival,
Increase of physical activity over time associated with lower HF risk
Effect of sacubitril/valsartan on the rate of heart failure (HF) hospitalisations as a time to first event analysis and as a recurrent event analysis of.
Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.
The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.
Presentation transcript:

Kaplan-Meier analysis of time to recurrent congestive heart failure or death in patients prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

Kaplan-Meier analysis of time to death in patients prescribed celecoxib, rofecoxib,or non-steroidal anti-inflammatory drugs Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

Baseline characteristics of patients with congestive heart failure prescribed celecoxib,rofecoxib,or non-steroidal anti-inflammatory drugs (NSAIDs) Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

Prescribing characteristics for patients given celecoxib,rofecoxib,or non-steroidal anti-inflammatory drugs (NSAIDs) Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

Kaplan-Meier analysis of time to recurrent congestive heart failure in patients prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

Unadjusted rates of study events in patients with congestive heart failure who were prescribed celecoxib,rofecoxib,or non-steroidal anti-inflammatory drugs (NSAIDs) Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

Adjusted hazard ratios (95%confidence intervals) for death and recurrent congestive heart failure, combined and alone, according to exposure group Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.